Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 18-Nov-24
Select bar for recommendation details.
Recommendations | 18-Nov-24 | |
---|---|---|
Buy | 9 | |
Outperform | 13 | |
Hold | 16 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 30 analysts offering 12 month price targets for Biogen Inc have a median target of 250.00, with a high estimate of 342.00 and a low estimate of 180.00. The median estimate represents a 60.26% increase from the last price of 156.00.
High | 119.2% | 342.00 |
Med | 60.3% | 250.00 |
Low | 15.4% | 180.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 11, 2025.
Average growth rate | +2.01% |
Average growth rate | -16.83% |
More ▼
Revenue history & estimates in USD
Average growth rate | -0.51% |
Average growth rate | -8.87% |
More ▼